Overview
The purpose of this study is to evaluate the contribution of autologous graft reinjection (lipofilling) in the treatment of dysaesthesic pulp.
Eligibility
Inclusion Criteria:
- Major patient (18 years old) and ≤ 75 years old
- Patient with unidigital trauma downstream of distal interphalangeal joint
- Treated by directed healing OR covered by a flap
- Presenting troublesome pulpal dysesthesia evolving for more than 6 months AND less than 24 months
- The discomfort must be objectified by a DN4 score greater than or equal to 4/10 (neuropathic pain)
- Patient does not have any allergy to the substances used, in particular anesthetic: xylocaine, adrenaline
Exclusion Criteria:
- Patient with cutaneous sepsis, or amputation upstream of distal interphalangeal, or reimplantation, or dysesthesia that has been in progress for more than 24 months, or multi-digital traumatism
- Refusal of the patient to integrate the protocol Or incapacity to consent
- Pregnant or breastfeeding woman
- Tumor history of the amputated finger